Procter & Gamble Health Ltd is an India based pharmaceutical company engaged in manufacturing and selling of healthcare products, viz., vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct & indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. Cosome, Evion, Neurobion, Nasivion, Polybion, Livogen and Seven Seas are some of the brands of the company. The geographical segments include sales in India and exports.
Company address
Cardinal Gracias Road, Ground Floor And First Floor, P&G Plaza, Mumbai, MH, 400099
Kuvera gives you rich data insights and peer comparison for informed stock investment decisions. Just import your stock portfolio from your broking platform to Kuvera to track your investments and place your buy / sell orders.
1. Login to the Kuvera app or website and go to Invest section.
2. Select stocks and search for Procter & Gamble Health Ltd or scroll over to Procter & Gamble Health Ltd
3. Once you have understood its performance and financials, tap on Buy. You will be taken to your existing brokerage account for completing the transaction.
What is the Share Price of Procter & Gamble Health Ltd?
The share price of Procter & Gamble Health Ltd stocks is ₹5,090.00 as on 28/04/2025
What is the Market Cap of Procter & Gamble Health Ltd?
Market capitalization or market cap in short, is the total value of all the stocks of a particular company. Market capitalization of Procter & Gamble Health Ltd stock is ₹8,449.1 Cr on 28/04/2025.
In which sector / industry does Procter & Gamble Health Ltd operate?
Procter & Gamble Health Ltd operates in Healthcare / Drug Manufacturers - Specialty & Generic.
What was the revenue of Procter & Gamble Health Ltd?
The revenue of Procter & Gamble Health Ltd as of 2024 was ₹1,129.5 Cr
What is the PE ratio of Procter & Gamble Health Ltd?
The price-to-earnings ratio (P/E ratio) in case of stocks of a company is the ratio between its
current share price relative to its earnings per share (EPS). A high P/E ratio indicates that the stock is
overvalued in relation to the earnings (revenue) generated. P/E ratio of Procter & Gamble Health Ltd is
35.72 as on 28/04/2025.
What is the 52 week high price of Procter & Gamble Health Ltd?
The 52 week high of Procter & Gamble Health Ltd stock is ₹5,835.95.
What is the 52 week low price of Procter & Gamble Health Ltd?
The 52 week low of Procter & Gamble Health Ltd stock is ₹4,640.30.
Can fractional shares of Procter & Gamble Health Ltd be purchased?
No, you cannot buy fractional shares of Procter & Gamble Health Ltd, or any listed Indian company as of now.